Figure 2.
Figure 2. Donor-derived cells are present in the PB from recipients of either wild-type or SHIP-/- BM cells. Aliquots of PB were collected from Pep3b recipients that received transplants 16 weeks previously of 5 × 105 BM cells from either SHIP+/+ (wild type; left panels) or SHIP-/- (right panels) donors. FACS staining and analysis were carried out as indicated in “Materials and methods.” Representative FACS profiles indicating the frequency of donor-derived (Ly5.2+; right quadrants) and endogenous (Ly5.2-; left quadrants) B-lymphoid (B220+) and myeloid (Mac-1/Gr-1+) cells are shown.

Donor-derived cells are present in the PB from recipients of either wild-type orSHIP-/-BM cells. Aliquots of PB were collected from Pep3b recipients that received transplants 16 weeks previously of 5 × 105 BM cells from either SHIP+/+ (wild type; left panels) or SHIP-/- (right panels) donors. FACS staining and analysis were carried out as indicated in “Materials and methods.” Representative FACS profiles indicating the frequency of donor-derived (Ly5.2+; right quadrants) and endogenous (Ly5.2-; left quadrants) B-lymphoid (B220+) and myeloid (Mac-1/Gr-1+) cells are shown.

Close Modal

or Create an Account

Close Modal
Close Modal